Search Results - "Kuraguchi, Mari"
-
1
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Published in Nature communications (17-02-2016)“…Despite compelling antitumour activity of antibodies targeting the programmed death 1 (PD-1): programmed death ligand 1 (PD-L1) immune checkpoint in lung…”
Get full text
Journal Article -
2
EGFR Inhibition Enhances the Cellular Uptake and Antitumor-Activity of the HER3 Antibody-Drug Conjugate HER3-DXd
Published in Cancer research (Chicago, Ill.) (01-01-2022)“…Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) are the standard-of-care treatment for -mutant non-small cell lung cancers (NSCLC)…”
Get full text
Journal Article -
3
Use of Ex Vivo Patient-Derived Tumor Organotypic Spheroids to Identify Combination Therapies for HER2 Mutant Non-Small Cell Lung Cancer
Published in Clinical cancer research (15-05-2020)“…Evaluating drug responses using primary patient-derived cells represents a potentially rapid and efficient approach to screening for new treatment approaches…”
Get full text
Journal Article -
4
Apc inhibition of Wnt signaling regulates supernumerary tooth formation during embryogenesis and throughout adulthood
Published in Development (Cambridge) (01-06-2009)“…The ablation of Apc function or the constitutive activation ofβ -catenin in embryonic mouse oral epithelium results in supernumerary tooth formation, but the…”
Get full text
Journal Article -
5
Adenomatous polyposis coli (APC) is required for normal development of skin and thymus
Published in PLoS genetics (01-09-2006)“…The tumor suppressor gene Apc (adenomatous polyposis coli) is a member of the Wnt signaling pathway that is involved in development and tumorigenesis…”
Get full text
Journal Article -
6
Genetic mechanisms in Apc-mediated mammary tumorigenesis
Published in PLoS genetics (01-02-2009)“…Many components of Wnt/beta-catenin signaling pathway also play critical roles in mammary tumor development, yet the role of the tumor suppressor gene APC…”
Get full text
Journal Article -
7
Haploinsufficiency of Flap Endonuclease (Fen1) Leads to Rapid Tumor Progression
Published in Proceedings of the National Academy of Sciences - PNAS (23-07-2002)“…Flap endonuclease (Fen1) is required for DNA replication and repair, and defects in the gene encoding Fen1 cause increased accumulation of mutations and genome…”
Get full text
Journal Article -
8
Mbd4 Inactivation Increases C→T Transition Mutations and Promotes Gastrointestinal Tumor Formation
Published in Proceedings of the National Academy of Sciences - PNAS (12-11-2002)“…Mbd4 (methyl-CpG binding domain 4) is a novel mammalian repair enzyme that has been implicated biochemically in the repair of mismatched G-T residues at…”
Get full text
Journal Article -
9
Novel roles for MLH3 deficiency and TLE6-like amplification in DNA mismatch repair-deficient gastrointestinal tumorigenesis and progression
Published in PLoS genetics (01-06-2008)“…DNA mismatch repair suppresses gastrointestinal tumorgenesis. Four mammalian E. coli MutL homologues heterodimerize to form three distinct complexes:…”
Get full text
Journal Article -
10
Loss of Rb1 in the gastrointestinal tract of Apc1638N mice promotes tumors of the cecum and proximal colon
Published in Proceedings of the National Academy of Sciences - PNAS (07-10-2008)“…To examine the role of Rb1 in gastrointestinal (GI) tumors, we generated mice with an Apc 1638N allele, Rb tm2brn floxed alleles, and a villin-cre transgene…”
Get full text
Journal Article -
11
Abstract 3286: B-hCD94/hNKG2A mice provide a preclinical tool for evaluating therapeutic antibodies targeting human NKG2A
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract The immune cell checkpoint NKG2A and its coreceptor, CD94, are expressed by many circulating NK cells and by a subset of CD8 T cells in tumors. When…”
Get full text
Journal Article -
12
Abstract 3993: In vivo efficacy of an anti-human IL11RA antibody in B-hIL11RA mice with APAP-induced liver damage
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract Acetaminophen (N-acetyl-p-aminophenol; APAP) overdose is a common cause of drug-induced acute liver injury, thereby making APAP administration a…”
Get full text
Journal Article -
13
Abstract 113: Generation and validation of a novel humanized IL-31/IL-31RA/OSM/OSMR mouse model
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract Oncostatin M (OSM) and interleukin-31 (IL-31) are two pleiotropic cytokines that share a common signaling receptor subunit, the OSM receptor beta…”
Get full text
Journal Article -
14
Abstract 5339: Establishment of a humanized IL5/IL5RA mouse model to evaluate modulators of eosinophilic inflammation in vivo
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract IL-5/IL-5R signaling plays a key role in the maturation, activation, survival, and recruitment of eosinophils to sites of inflammation. Targeting this…”
Get full text
Journal Article -
15
Abstract 5346: A novel humanized CD16A model to evaluate efficacy of human antibody therapeutics in triggering ADCC
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract Antibody-dependent cellular cytotoxicity (ADCC) is a mechanism by which immune effector cells engage the Fc portion of antibodies bound to antigen on…”
Get full text
Journal Article -
16
Abstract 2089: Evaluating in vivo efficacy of anti-TSLP antibodies in humanized B-hTSLP/hTSLPR mice
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Expression of the epithelial cytokine, thymic stromal lymphopoietin (TSLP), has been observed across several barrier surfaces and plays a critical…”
Get full text
Journal Article -
17
Abstract 1643: B-hIL12A/hIL12B/hIL12RB1/hIL12RB2: A novel animal model for generation of IL12 therapies
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract The pro-inflammatory cytokine, interleukin 12 (IL12), is primarily responsible for cell-mediated immunity and is chiefly produced by antigen…”
Get full text
Journal Article -
18
Abstract 4806: Exploring optimal targeted combination therapies with neratinib for HER2 mutated NSCLC
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Genetic alterations which constitutively activate human epidermal growth factor receptor 2 (HER2; ERBB2) without overexpression have been observed in…”
Get full text
Journal Article -
19
Tumor-associated Apc mutations in Mlh1-/- Apc1638N mice reveal a mutational signature of Mlh1 deficiency
Published in Oncogene (23-11-2000)“…Apc1638N mice, which are heterozygous for a germline mutation in Apc, typically develop three to five spontaneous intestinal tumors per animal. In most cases…”
Get full text
Journal Article -
20
Abstract 4778: Assessing efficacy of neratinib in HER2-driven lung cancer
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract HER2 mutations have been classified as oncogenic drivers that are present in 2-4% of lung adenocarcinomas. However, due to limited preclinical studies…”
Get full text
Journal Article